Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease

Keyphrases

• Genetic Risk 100%
• Alzheimer's Disease 100%
• Cerebral Glucose Metabolism 100%
• Laboratory Animals 100%
• Transgenic Mice 40%
• Cognitively Normal 40%
• Alzheimer 40%
• Brain Imaging 40%
• Alzheimer's Dementia 40%
• Positron Emission Tomography Study 20%
• Preventive Treatment 20%
• Protein-coding Genes 20%
• Late Medieval Period 20%
• Autoradiography 20%
• Potential Indicators 20%
• Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) 20%
• Apolipoprotein E 20%
• Posterior Cingulate Cortex 20%
• Amyloid Precursor Protein 20%
• Functional Brain Imaging 20%
• Disease Mechanisms 20%
• Susceptibility Genes 20%
• Fluorodeoxyglucose 20%
• Alzheimer's Disease Prevention 20%

Neuroscience

• Metabolic Pathway 100%
• Alzheimer's Disease 100%
• Brain Imaging 33%
• Epileptic Absence 16%
• Positron Emission Tomography 16%
• Imaging Technique 16%
• Autoradiograph 16%
• Amyloid Precursor Protein 16%
• Posterior Cingulate 16%
• Cingulate Cortex 16%
• Apolipoprotein E 16%